How do you approach the use of newer anti-seizure medications for epilepsy patients on DOACs?

Levetiracetam and valproic acid:

• A nested case-control study published in 2021 (Gronich et al., PMID 34287842) in patients with afib identified an increased risk of stroke/systemic embolism with levetiracetam and valproic acid. This was followed by a few retrospective studies published in 2022 and ...